☰

Jeanne V. Zborowski, Ph.D. - Publications

Affiliations: 
2000 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Public Health, Epidemiology
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Talbott EO, Zborowski J, Rager J, Stragand JR. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? Vascular Health and Risk Management. 4: 453-62. PMID 18561521 DOI: 10.2147/Vhrm.S1452  0.398
2007 Talbott EO, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women. Journal of Women's Health (2002). 16: 191-7. PMID 17388735 DOI: 10.1089/Jwh.2006.0098  0.346
2004 Patel AS, Talbott EO, Zborowski JV, Rycheck JA, Dell D, Xu X, Schwerha J. Risk of cancer as a result of community exposure to gasoline vapors. Archives of Environmental Health. 59: 497-503. PMID 16425659 DOI: 10.1080/00039890409605165  0.326
2004 Talbott EO, Zborowski JV, Boudreaux MY, McHugh-Pemu KP, Sutton-Tyrrell K, Guzick DS. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 89: 6061-7. PMID 15579759 DOI: 10.1210/Jc.2003-032110  0.382
2004 Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 89: 5454-61. PMID 15531497 DOI: 10.1210/Jc.2003-032237  0.419
2004 Wright CE, Zborowski JV, Talbott EO, McHugh-Pemu K, Youk A. Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 28: 1026-32. PMID 15159768 DOI: 10.1038/Sj.Ijo.0802661  0.354
2004 Talbott EO, Zborowski JV, Boudraux MY. Do women with polysyndrome ovary syndrome have an increased risk of cardiovascular disease?: Review of the evidence Minerva Ginecologica. 56: 27-39. PMID 14973408  0.328
2003 Talbott EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick DS. Cardiovascular risk in women with polycystic ovary syndrome Infertility and Reproductive Medicine Clinics of North America. 14: 603-622. DOI: 10.1016/S0889-8545(05)70189-3  0.41
2003 Talbott EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick DS. Cardiovascular risk in women with polycystic ovary syndrome Infertility and Reproductive Medicine Clinics of North America. 14: 603-622. DOI: 10.1016/S0889-8545(05)70189-3  0.336
2002 Remsberg KE, Talbott EO, Zborowski JV, Evans RW, McHugh-Pemu K. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome. Fertility and Sterility. 78: 479-86. PMID 12215321 DOI: 10.1016/S0015-0282(02)03303-4  0.409
2001 Zborowski JV, Talbott EO, Cauley JA. Polycystic ovary syndrome, androgen excess, and the impact on bone. Obstetrics and Gynecology Clinics of North America. 28: 135-51, vii-viii. PMID 11292999 DOI: 10.1016/S0889-8545(05)70190-X  0.456
2000 Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 2414-21. PMID 11073846  0.354
2000 Zborowski JV, Cauley JA, Talbott EO, Guzick DS, Winters SJ. Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone. The Journal of Clinical Endocrinology and Metabolism. 85: 3496-506. PMID 11061489 DOI: 10.1210/Jcem.85.10.6902  0.468
2000 Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertility and Sterility. 73: 724-9. PMID 10731532 DOI: 10.1097/00006254-200009000-00017  0.371
Show low-probability matches.